share_log

Wells Fargo Maintains Equal-Weight on Ventyx Biosciences, Lowers Price Target to $3

Wells Fargo Maintains Equal-Weight on Ventyx Biosciences, Lowers Price Target to $3

富国银行维持对Ventyx Biosciences的同等权重,将目标股价下调至3美元
Benzinga ·  2023/12/19 08:30

Wells Fargo analyst Derek Archila maintains Ventyx Biosciences (NASDAQ:VTYX) with a Equal-Weight and lowers the price target from $8 to $3.

富国银行分析师德里克·阿奇拉维持Ventyx Biosciences(纳斯达克股票代码:VTYX)的权重持平,并将目标股价从8美元下调至3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发